FDA’s Center for Veterinary Medicine Approves First Drug to Treat Cancer in Dogs

June 3, 2009

The FDA’s Center for Veterinary Medicine today announces the approval of Palladia (toceranib phosphate), to treat canine skin-based mast cell tumors. The drug is approved to treat the tumors with or without regional lymph node involvement.

Palladia is a Pfizer Animal Health product and will be available through veterinarians in 2010.

For more information about this new drug approval, please see the FDA Press Release and FOI Summary.